FDAFDA · Food and drugs·Recall number D-0035-2020
Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0202-02
Published October 2, 2019 · Recall initiated: September 12, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Shire Human Genetic Therapies, Inc.
- Distributor
- Product was distributed throughout the United States.
- Lot
- 08569357, exp 4/30/2020; 07983652, 08544833, exp 6/30/2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.